Rankings
▼
Calendar
NVAX Q3 2017 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+158.5% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$42M
-498.4% margin
Net Income
-$45M
-534.1% margin
EPS (Diluted)
$-3.01
QoQ Revenue Growth
+24.1%
Cash Flow
Operating Cash Flow
-$37M
Free Cash Flow
-$38M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$334M
Total Liabilities
$408M
Stockholders' Equity
-$74M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$3M
+158.5%
Gross Profit
$8M
$3M
+158.5%
Operating Income
-$42M
-$63M
+34.2%
Net Income
-$45M
-$66M
+32.7%
← FY 2017
All Quarters
Q4 2017 →